Company Filing History:
Years Active: 2003-2012
Title: Kyung Koo Kang: Innovator in Pharmaceutical Solutions
Introduction
Kyung Koo Kang is a notable inventor based in Kyunggi-do, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of prostatic hyperplasia and impotence. With a total of 2 patents, his work has the potential to impact many lives positively.
Latest Patents
Kang's latest patents include an agent for the prevention and treatment of prostatic hyperplasia, which comprises a pyrazolopyrimidinone compound. This invention addresses benign prostatic hyperplasia (BPH) and lower urinary tract symptoms (LUTS) associated with BPH. The agent works by providing nitric oxides through the inhibition of PDE-5, which relaxes urethral and prostatic smooth muscles, thereby lowering intraurethral pressure. This innovative solution not only has a shorter time to reach maximum blood concentration but also boasts a longer half-life compared to other PDE-5 inhibitors, reducing the frequency of administration and minimizing side effects.
Another significant patent by Kang involves pyrazolopyrimidinone derivatives for the treatment of impotence. This invention details the preparation method and pharmaceutical compositions containing these derivatives, which are effective in treating male sexual dysfunction with reduced side effects.
Career Highlights
Throughout his career, Kyung Koo Kang has worked with reputable companies such as Dong-a Pharm Co., Ltd. and Dong-a Pharmtech Co., Ltd. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.
Collaborations
Kang has collaborated with notable colleagues, including Moohi Yoo and Byoung Ok Ahn, further enhancing his research and development efforts in the pharmaceutical field.
Conclusion
Kyung Koo Kang's contributions to pharmaceutical innovations, particularly in the treatment of prostatic hyperplasia and impotence, showcase his dedication to improving healthcare solutions. His patents reflect a commitment to developing effective and safe treatments for patients.